Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $979,499 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Feb 2025 13:59 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 11 Feb 2025 | Sale | 363 | 28.5388 | 10,360 | D |
| 30 Jan 2025 12:01 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 29 Jan 2025 | Sale | 365 | 29.5236 | 10,776 | D |
| 23 Jan 2025 15:23 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 22 Jan 2025 | Sale | 1,396 | 30.4255 | 42,474 | D |
| 21 Jan 2025 15:59 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 17 Jan 2025 | Sale | 1,235 | 29.9582 | 36,998 | D |
| 14 Jan 2025 16:10 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 13 Jan 2025 | Sale | 1,599 | 28.7021 | 45,895 | D |
| 19 Mar 2024 16:03 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 18 Mar 2024 | Sale | 9,913 | 56.9 | 564,050 | D |
| 13 Feb 2024 16:38 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 12 Feb 2024 | Sale | 597 | 67.7669 | 40,457 | D |
| 31 Jan 2024 16:18 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 29 Jan 2024 | Sale | 367 | 64.1382 | 23,539 | D |
| 23 Jan 2024 18:01 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 22 Jan 2024 | Sale | 1,384 | 64.996 | 89,954 | D |
| 17 Jan 2024 16:41 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 16 Jan 2024 | Sale | 1,631 | 66.8086 | 108,965 | D |
| 24 Oct 2023 16:18 | APLS | Apellis Pharmaceuticals Inc | DELONG MARK JEFFREY | Chief Business & Strat Officer | 23 Oct 2023 | Sale | 131 | 46.0362 | 6,031 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)